CCBI Tech Venture
VC Fund
Suzhou, China
CCBI Tech Venture is a VC fund in Suzhou focused on Health Care and Biotechnology. CCBI Tech Venture(Suzhou) Combined Debt & Equity Private Equity Fund LLP is an equity investment fund targeting at technological innovation-oriented enterprises which is jointly established by CCB International and CCB Suzhou Branch; the CCB Tech Venture focuses on areas including biology nanotechnology, artificial intelligence, informationtechnology, high-end manufacturing, Internet, healthcare and huge consumer market. The CCBI Tech Venture fully utilizes the comprehensive advantages of China Construction Bank and of China Construction Bank's investment and investment banking capabilities, and establishes a layout of high-growth and high-quality enterprises, in order to promote the growth of the enterprises by the investment-loan-connected innovative model.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries CCBI Tech Venture invests in
Stages CCBI Tech Venture invests in
Countries CCBI Tech Venture invests in
Investment Focus
Industry
- Health Care 2 (67%)
- Biotechnology 2 (67%)
- Medical 1 (33%)
- Software 1 (33%)
- Life Science 1 (33%)
Stage
- Series B 2 (67%)
- Series C 1 (33%)
Country
- China 1 (33%)
- Singapore 1 (33%)
- United States 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Mirxes
|
MiRXES offers discover, develop, and deliver accurate preventive healthcare solutions for cancer, cardiovascular, metabolic and infectious diseases, and make them accessible to all. | $77M / Series C / Jul 08, 2021 | |
Pico Interactive
|
Pico Interactive focuses on developing innovative VR technology solutions.With operations in the United States and China, Pico is deeply committed to VR hardware and software R&D, VR application development and cutting edge industrial design.Pico’s goals are to deliver premium VR products to both consumers and businesses alike, and topartner with content creators to bring amazing VR experiences to people everywhere.Founded in 2015, They have grown to over 300 team members including product design, R&D, software development, QA and business development. | $37.4M / Series B / Mar 10, 2021 | |
WuXi Diagnostics
|
WuXi Diagnostics builds an innovative model that enables diagnostic product innovation, generates clinical insights, and benefits the health of mankind through precision diagnosis and treatment. | $150M / Series B / Feb 23, 2021 |
Co-Investors
ABC International
1 deal together
Charoen Pokphand Group
1 deal together
Co-Stone Venture Capital
1 deal together
EDBI
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does CCBI Tech Venture invest in?
CCBI Tech Venture invests primarily in Health Care, Biotechnology and Medical startups, most often at Series B and Series C stage. Most of the 3 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did CCBI Tech Venture last invest?
The most recent investment recorded for CCBI Tech Venture closed in Jul 2021. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
